Atlas Trials

Low- vs High-Dose Sirolimus With Prednisolone for KHE and KMP

Clinical trial NCT07656909 · RECRUITING

Trial details

NCT number
NCT07656909
Sponsor
Yi Ji
Status
RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Kaposiform Hemangioendothelioma (KHE)Kasabach Merritt Phenomenon
Start date
2026-06-16
Primary completion
2027-12-31
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.